In the first place, the Commission would like to emphasize that, from the medical point of view, the question of competition between natural and synthetic antimalarial remedies does not arise. The treatment of malaria by the physician would not be advanced by producing quinine synthetically or by producing synthetic remedies with an action and toxicity so similar to the action and toxicity of quinine that they could be used only as ' substitutes' for that drug. From the medical point of view, what is required of a new product is that it should be effective for some therapeutic or prophylactic purpose for which quinine is known to fail, and?if it is so?that its use for the particular purpose should involve the patient in no risk of toxic-symptoms. The latter is as important as the former.
Having regard to these criteria, the following brief recapitulation of the uses to which available specific remedies are applicable may now be given: [March, 1934 Sporozoite therapy (true causal prophylaxis 
